As the American Diabetes…
As the American Diabetes Association 2026 Scientific Sessions kicked off [...]
As the American Diabetes Association 2026 Scientific Sessions kicked off [...]
When it comes to turning T-cell therapies toward autoimmune diseases, [...]
Affibody may not have expected to be working on izokibep [...]
Longtime FDA leader Lola Fashoyin-Aje, M.D., is adapting to a [...]
On Thursday, the public had the first chance to air [...]
A stimulator of thyroid hormone receptors in the brain has [...]
Two federal lawmakers have introduced a bill seeking to apply [...]
Parabilis Medicines is gearing up for an IPO that could [...]
Regeneron has expanded its research alliance with CytomX Therapeutics, paying [...]
Ascidian Therapeutics and Eli Lilly have signed a research collaboration [...]